Doubts over side-effects of the AstraZeneca coronavirus vaccine have risen in Europe

Doubts over side-effects of the AstraZeneca coronavirus vaccine have risen in Europe

Ghana has recorded 88, 228 COVID 19 cases and 698 deaths since the outbreak of the COVID 19 pandemic. Following the approval of the Indian-made jab and Russia’s Sputnik V by the Ghana Food and Drug Authority, Ghana has become the first recipient of the Coronavirus vaccine from Covax.

The government of Ghana target 20 million of its population to be vaccinated by the end of the year. Hence, as proof of the safety of the jabs before the deployment of the vaccine. President Nana Akufo-Addo together with the first lady Rebecca Akufo-Addo has received a shot of the Oxford/AstraZeneca vaccine in a live broadcast. Since then no aligning issues have been reported in any part of the country.

Meanwhile, in Europe, concerns have been raised over the side-effects link to AstraZeneca’s coronavirus vaccine after it has been administered. Besides, several countries including France, Italy, and Spain have suspended the use of the vaccine, with Germany the latest country to pause the rollout. The decision came after a small number of patients who received the vaccine developed blood clots. However, a direct link between the vaccine and the reported blood clots has not been conclusively proven.

However, about 17 million people in the Europe and UK have received a dose of the vaccine with fewer than 40 cases of blood clots reported as of last week, AstraZeneca reported.

A follow-up to this development Vaccine Safety experts from the World Health Organization (WHO) is meeting to review the Oxford-AstraZeneca jab.

Source: BBC news

Leave a Reply

Your email address will not be published.